Literature DB >> 34662191

Phage Activity against Planktonic and Biofilm Staphylococcus aureus Periprosthetic Joint Infection Isolates.

Katherine M C Totten1,2, Robin Patel1,3.   

Abstract

We recently reported the successful treatment of a case of periprosthetic joint infection (PJI) with phage. Phage activity against bacteria causing PJI has not been systematically evaluated. Here, we examined the in vitro activity of seven phages against 122 clinical isolates of Staphylococcus aureus recovered between April 1999 and February 2018 from subjects with PJI. Phages were assessed against planktonic and biofilm phenotypes. Activity of individual phages was demonstrated against up to 73% of bacterial isolates in the planktonic state and up to 100% of biofilms formed by isolates that were planktonically phage susceptible. Susceptibility to phage was not correlated with small-colony-variant phenotype for planktonic or biofilm bacteria; correlation between antibiotic susceptibility and planktonic phage susceptibility and between biofilm phage susceptibility and strength of biofilm formation were noted under select conditions. These results demonstrate that phages can infect S. aureus causing PJI in both planktonic and biofilm phenotypes, and thus are worthy of investigation as an alternative or addition to antibiotics in this setting.

Entities:  

Keywords:  antibiotic resistance; biofilm; periprosthetic joint infection; phage

Mesh:

Substances:

Year:  2021        PMID: 34662191      PMCID: PMC8765226          DOI: 10.1128/AAC.01879-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.938


  71 in total

1.  Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content.

Authors:  S O'Flaherty; A Coffey; R Edwards; W Meaney; G F Fitzgerald; R P Ross
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

Review 2.  Oral antibiotic treatment of staphylococcal bone and joint infections in adults.

Authors:  Baek-Nam Kim; Eu Suk Kim; Myoung-Don Oh
Journal:  J Antimicrob Chemother       Date:  2013-09-26       Impact factor: 5.790

Review 3.  Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms.

Authors:  Mads Frederik Hansen; Sine Lo Svenningsen; Henriette Lyng Røder; Mathias Middelboe; Mette Burmølle
Journal:  Trends Microbiol       Date:  2019-05-22       Impact factor: 17.079

4.  Novel bacteriophage therapy for treatment of left ventricular assist device infection.

Authors:  Saima Aslam; Victor Pretorius; Susan M Lehman; Sandra Morales; Robert T Schooley
Journal:  J Heart Lung Transplant       Date:  2019-01-07       Impact factor: 10.247

5.  Lytic infection of Escherichia coli biofilms by bacteriophage T4.

Authors:  M M Doolittle; J J Cooney; D E Caldwell
Journal:  Can J Microbiol       Date:  1995-01       Impact factor: 2.419

Review 6.  Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections.

Authors:  Zarique Z Akanda; Mariam Taha; Hesham Abdelbary
Journal:  J Orthop Res       Date:  2017-11-22       Impact factor: 3.494

7.  Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.

Authors:  L Tuchscherr; C A Kreis; V Hoerr; L Flint; M Hachmeister; J Geraci; S Bremer-Streck; M Kiehntopf; E Medina; M Kribus; M Raschke; M Pletz; G Peters; B Löffler
Journal:  J Antimicrob Chemother       Date:  2015-11-20       Impact factor: 5.790

8.  Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.

Authors:  Borg Leijtens; Joris B W Elbers; Patrick D Sturm; Bart Jan Kullberg; Berend W Schreurs
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090

Review 9.  Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?

Authors:  Barbara Maciejewska; Tomasz Olszak; Zuzanna Drulis-Kawa
Journal:  Appl Microbiol Biotechnol       Date:  2018-02-13       Impact factor: 4.813

10.  In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their Corresponding Wild Types.

Authors:  Nina Schleimer; Ursula Kaspar; Dennis Knaack; Christof von Eiff; Sonja Molinaro; Holger Grallert; Evgeny A Idelevich; Karsten Becker
Journal:  Int J Mol Sci       Date:  2019-02-07       Impact factor: 5.923

View more
  1 in total

1.  Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro: Bacteriophage-Antibiotic Combination.

Authors:  Razieh Kebriaei; Katherine L Lev; Rahi M Shah; Kyle C Stamper; Dana J Holger; Taylor Morrisette; Ashlan J Kunz Coyne; Susan M Lehman; Michael J Rybak
Journal:  Microbiol Spectr       Date:  2022-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.